|
CURX Curanex Pharmaceuticals Inc 2025942 |
| Income Statement |
|
Net Income
|
2026-03-31
|
$-3,150,228.00 |
| Balance Sheet |
|
Current Assets
|
$8,093,718.00 |
|
Assets
|
$8,411,292.00 |
|
Current Liabilities
|
$128,734.00 |
|
Liabilities
|
$332,644.00 |
|
Equity
|
$8,078,648.00 |
|
Shares Out
|
28364812.00 |
| Cash Flow Statement |
|
Operating Cash Flow
|
$-954,560.00 |
| Market Analysis |
Market Cap
|
$5,389,314.28 |
|
Price
|
$0.20 |
|
BVPS
|
0.28 |
|
PB
|
0.68 |
|
EPS
|
-0.11 |
|
| Dividends |
|
Dividend Data Last Updated
|
2026-08-01 09:31:45 |
|
|
| Earnings |
|
Earnings Last Updated
|
2026-08-03 10:01:45 |
|
|
|
Find a discrepancy? The most accurate way to find company fundamental data is to view CURX documents filed with the SEC.
CURX Filings
Clear
